MedTrace Logo

Retrospective Record-review Study in Patients Who Had Diabetic Foot Ulcer

NCT05135130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-03-06

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the medical cost of illness for DFUs on the patients who had used ON101 or Aquacel® in the ON101CLCT02 trial.

Conditions

  • Diabetic Foot Ulcer

Interventions

DRUG

ON101 Cream

Not applicable in this retrospective study

Sponsors & Collaborators

  • Oneness Biotech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Shyi-Gen Chen, MD · Oneness Biotech Co., Ltd.

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-04
Primary Completion
2022-01-20
Completion
2022-01-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05135130 on ClinicalTrials.gov